Table 7.
Side effects | Statin Users (N=4332) | Non‐Statin Users (N=1386) | Odds Ratio | CI |
---|---|---|---|---|
N (%) 308 (7) | N (%) 34 (2) | |||
Hepatitis | 20 (0.46) | 2 (0.14) | 3.2 | 0.7–13.7 |
Transaminitis | 16 (0.37) | 1 (0.07) | 5.1 | 0.7–38.5 |
Myopathy | 75 (1.73) | 12 (0.86) | 2.0 | 1.1–3.7 |
Myositis/myalgia | 23 (0.53) | 4 (0.29) | 1.8 | 0.6–5.3 |
Sleep disorders | 173 (4.01) | 15 (1.06) | 3.9 | 2.3–6.6 |
Rhabdomyolysis | 1 (0.02) | 0 (0) | NA | NA |
NA indicates quasi‐complete separation.